| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
20,798 |
13,560 |
$489K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
302 |
295 |
$28K |
| 90651 |
|
80 |
80 |
$20K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,456 |
1,179 |
$19K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
370 |
350 |
$11K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,280 |
1,230 |
$10K |
| 90746 |
|
162 |
162 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
753 |
699 |
$8K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
70 |
70 |
$6K |
| 90750 |
|
26 |
26 |
$5K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
63 |
62 |
$4K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
320 |
277 |
$3K |
| 90670 |
|
16 |
16 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
455 |
401 |
$2K |
| 90658 |
|
176 |
173 |
$2K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
173 |
144 |
$1K |
| 90734 |
|
24 |
24 |
$1K |
| 90688 |
|
216 |
216 |
$1K |
| 90715 |
|
15 |
15 |
$390.91 |
| 36415 |
Collection of venous blood by venipuncture |
432 |
428 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
146 |
146 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
138 |
138 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
194 |
194 |
$0.00 |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
56 |
56 |
$0.00 |
| Q2037 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) |
51 |
51 |
$0.00 |